Omeprazole is a substituted benzimidazole and a potent proton pump inhibitor used to treat gastroesophageal reflux disease, peptic ulcers, and other acid-related gastrointestinal conditions. By irreversibly… Read more



























![Chemical structure of Sodium 1-(5-methoxy-1H-benzo[d]imidazol-2-yl)-3,5-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3049389-33-2-Sodium-1-5-methoxy-1H-benzodimidazol-2-yl-35-dimethyl-4-oxo-14-dihydropyridine-2-carboxylate.png&w=3840&q=75)
Omeprazole is a substituted benzimidazole and a potent proton pump inhibitor used to treat gastroesophageal reflux disease, peptic ulcers, and other acid-related gastrointestinal conditions. By irreversibly blocking the H+/K+ ATPase enzyme in gastric parietal cells, it effectively suppresses gastric acid secretion. Laboratories require a comprehensive range of Omeprazole reference standards, including degradation products, synthetic intermediates, and process-related impurities, to ensure rigorous quality control and regulatory compliance. These compounds are essential for accurate impurity profiling and the development or validation of stability-indicating analytical methods. Furthermore, stable isotope labelled compounds serve as vital internal standards in liquid chromatography-mass spectrometry, enabling precise quantification of the parent drug and its metabolites in complex matrices. Providing these specialized materials supports the pharmaceutical industry in maintaining consistent product quality and adhering to stringent pharmacopeial standards throughout the drug development and manufacturing lifecycle.